Leslie Holsinger

2020

In 2020, Leslie Holsinger earned a total compensation of $9.2M as Executive Vice President of Research and Development at Cortexyme, a 1,977% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$162,000
Option Awards$8,631,100
Salary$405,000
Total$9,198,100

Holsinger received $8.6M in option awards, accounting for 94% of the total pay in 2020.

Holsinger also received $162K in non-equity incentive plan and $405K in salary.

Rankings

In 2020, Leslie Holsinger's compensation ranked 953rd out of 13,090 executives tracked by ExecPay. In other words, Holsinger earned more than 92.7% of executives.

ClassificationRankingPercentile
All
953
out of 13,090
93rd
Division
Manufacturing
333
out of 5,620
94th
Major group
Chemicals And Allied Products
110
out of 2,253
95th
Industry group
Drugs
97
out of 1,953
95th
Industry
Biological Products, Except Diagnostic Substances
23
out of 411
94th
Source: SEC filing on April 29, 2021.

Holsinger's colleagues

We found four more compensation records of executives who worked with Leslie Holsinger at Cortexyme in 2020.

2020

Casey Lynch

Cortexyme

Chief Executive Officer

2020

Caryn McDowell

Cortexyme

Secretary

2020

Christopher Lowe

Cortexyme

Chief Financial Officer

2020

Michael Detke

Cortexyme

Chief Medical Officer

News

In-depth

You may also like